1. Home
  2. INGN vs FATE Comparison

INGN vs FATE Comparison

Compare INGN & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

N/A

Current Price

$6.27

Market Cap

173.2M

Sector

Health Care

ML Signal

N/A

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

N/A

Current Price

$1.23

Market Cap

139.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INGN
FATE
Founded
2001
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.2M
139.6M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
INGN
FATE
Price
$6.27
$1.23
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$11.00
$4.10
AVG Volume (30 Days)
327.6K
1.5M
Earning Date
05-18-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
43.42
29.88
EPS
N/A
N/A
Revenue
$348,668,000.00
$6,646,000.00
Revenue This Year
$7.92
N/A
Revenue Next Year
$7.86
$1.05
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$5.34
$0.66
52 Week High
$9.13
$1.94

Technical Indicators

Market Signals
Indicator
INGN
FATE
Relative Strength Index (RSI) 52.04 43.49
Support Level $5.67 $0.96
Resistance Level $7.12 $1.35
Average True Range (ATR) 0.42 0.13
MACD 0.03 -0.03
Stochastic Oscillator 61.92 3.09

Price Performance

Historical Comparison
INGN
FATE

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: